In the context of allogeneic hematopoietic cell transplants, for example, where macrophages play an immunosuppressive role to limit the acute graft-versus-host disease (GvHD), anti-CSF1R treatment inhibits the total macrophage population and thereby aggravates GvHD [198]. Here, CSF1R is linked to graft versus host disease.